Intellectual Property

  • December 16, 2024

    Oracle's 'Copyright War' Will Go On, 9th Circ. Says

    Ninth Circuit judges decided on Monday that a "pitched copyright war" going for over a decade between Oracle and a software company that markets third-party software support to Oracle customers has not gone on for long enough, finding that a Nevada federal judge turned out to be quite wrong about what constitutes a "derivative" work.

  • December 16, 2024

    Health Education Biz Infringed Training Materials, NJ Suit Says

    A healthcare education company has accused a rival of infringing copyright-protected training materials for medical staff working in assisted living facilities, saying in a suit filed in New Jersey federal court that the copying is "blatantly obvious."

  • December 16, 2024

    9th Circ. Won't Revive Suit Over Starz Strip Club Drama

    The Ninth Circuit on Monday refused to revive a playwright's lawsuit claiming that Starz Entertainment copied her stage musical for the strip club drama series "P-Valley," saying the works weren't substantially close to one another.

  • December 16, 2024

    Amazon Ordered To Pay Patent Biz For New Alexa Users Too

    A Delaware federal judge says Amazon has to pay around 70 cents for every new Alexa user to a company that owns patents developed by a defunct voice technology startup, in addition to the $40 million it already owes after losing a jury trial last year.

  • December 16, 2024

    The Biggest Patent Decisions Of 2024

    This year's notable patent decisions from the Federal Circuit provided clearer guidelines on double patenting and opened the door for new ways to invalidate design patents. Here's a look at the cases from 2024 that will shape patent litigation going forward.

  • December 16, 2024

    Allele, Regeneron Settle COVID Treatment Patent Suit

    Allele Biotechnology and Regeneron Pharmaceuticals have settled litigation accusing the latter of infringing a patent used in developing treatments and vaccines for COVID-19, a New York federal judge said Monday.

  • December 16, 2024

    Supreme Court Rejects Salix Appeal In IBS Drug Case

    The U.S. Supreme Court has turned away a bid by a Bausch Health unit to undo a Federal Circuit ruling that invalidated some of its patents on a blockbuster drug for irritable bowel syndrome with diarrhea.

  • December 16, 2024

    Knicks Blame Raptors Arbitration Delay On Silver 'Conflict'

    The New York Knicks reiterated their claim that National Basketball Association commissioner Adam Silver is biased against the franchise and incapable of arbitrating their data-theft dispute with the Toronto Raptors, accusing Silver of a "clear conflict of interest.''

  • December 16, 2024

    High Court Bar's Future: Latham's Roman Martinez

    Roman Martinez of Latham & Watkins LLP approaches oral arguments before the U.S. Supreme Court as if they were just another dinner with family or friends — people he's argued with since he was a kid.

  • December 16, 2024

    Chipmaker Arm Settles UPC, US IP Litigation With Rival

    The Unified Patent Court has granted two computer chip companies permission to pull out of their litigation in Europe after the pair inked an agreement ending their parallel U.S. feud.

  • December 16, 2024

    Gibson Dunn Guides Vera Wang In Sale Of IP To WHP Global

    New York-based brand management firm WHP Global, advised by Kirkland & Ellis LLP and Pryor Cashman LLP, on Monday announced that it has agreed to buy all the intellectual property of Gibson Dunn & Crutcher LLP-advised luxury designer brand Vera Wang.

  • December 13, 2024

    NCAA, Pac-12, USC Say Reggie Bush Filed NIL Suit Too Late

    The NCAA, the University of Southern California and the Pac-12 Conference urged a Los Angeles state court to toss former USC star running back Reggie Bush's lawsuit accusing them of profiting off his fame without compensating him, saying Bush waited "far too long" to sue.

  • December 13, 2024

    Prindle Goetz Says Attys Took Trade Secrets To Rival Firm

    Prindle Goetz Barnes & Reinholtz LLP sued two former nonequity partners in California state court Thursday, accusing them of taking its confidential billing, compensation and client listing information with them in late 2022 before jumping to a rival law firm launched by a former equity owner at the law firm.

  • December 13, 2024

    Liner Co. Seeks PTAB Sanctions For Alleged False Testimony

    After receiving the Patent Trial and Appeal Board's green light Friday, Omega Liner Co. quickly requested sanctions against German packaging company Buergofol GmbH, whose liner patent Omega is challenging, accusing Buergofol's counsel of knowingly submitting false testimony to the board.

  • December 13, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen a group of franchise operators hit Vodafone with a £120 million ($151 million) claim for allegedly imposing commission cuts, green energy tycoon Dale Vince pursue another libel action against the publisher of the Daily Mail, and parcel delivery giant Yodel face a claim by an investor that helped save it from collapse earlier in the year.

  • December 13, 2024

    Judge Finds Wireless Patent Claim Indefinite In Samsung Feud

    A Delaware federal magistrate judge has sided with Samsung on how to interpret a key claim in a wireless communications patent it was accused of infringing, finding the term was indefinite.

  • December 13, 2024

    Tesla Gets PTAB To Cut Some Claims In 2 AI Vehicle Patents

    The Patent Trial and Appeal Board has found that most of the challenged claims across two patents related to the use of artificial intelligence in self-driving vehicles are invalid, handing a win to challenger Tesla.

  • December 13, 2024

    ITC To Review Design Patent Case Over Blue-Soled Shoes

    The U.S. International Trade Commission has agreed to investigate whether a New York-based company and a group of overseas entities are importing women's flats that infringe design patents belonging to the maker of Tieks shoes.

  • December 13, 2024

    ByteDance Ex-Coder Perjured Himself In Suit, Judge Finds

    A California federal judge imposed terminating sanctions against a former engineer at TikTok's parent company, finding he committed perjury in a suit alleging he was wrongly fired and ordered the dispute to arbitration.

  • December 13, 2024

    'Copycat' Nantucket Wine Event Ordered To Issue Retraction

    A Massachusetts liquor distributor was ordered Friday by a federal judge to post a bold-type correction and issue press releases retracting claims that it had acquired and "re-branded" a long-running Nantucket wine and food festival.

  • December 13, 2024

    What's Left In $400M Skinny Label Row? A Lot, Court Says

    A number of key issues remain live in the $400 million fight between Teva Pharmaceuticals and GlaxoSmithKline over whether the generic-drug maker induced healthcare providers to infringe the brand-name company's heart drug patent, including the availability of a new trial, a Delaware federal judge has said.

  • December 13, 2024

    Ex-Judges, Atty Group Back Newman In Suspension Lawsuit

    U.S. Circuit Judge Pauline Newman has received more support at the D.C. Circuit in her case over the suspension her colleagues imposed on her for refusing to participate in an investigation into her fitness to serve as a Federal Circuit judge, this time from a group of former federal judges and the Bar Association of the District of Columbia.

  • December 13, 2024

    Off The Bench: PE Buys In On NFL, WWE Abuse Suit Back On

    In this week's Off The Bench, two teams usher in a new era for the NFL by bringing in private equity investors, a suit accusing the WWE and Vince McMahon of sexual abuse and trafficking picks back up while a federal investigation continues, and a private equity giant and NHL owner passes away.

  • December 12, 2024

    Moderna Fires Back With Counterclaims In GSK RSV Vax Suit

    Moderna Inc. on Thursday lodged counterclaims in Delaware federal court accusing GlaxoSmithKline of failing to develop its own vaccine for respiratory syncytial virus, and then "resorting to the courtroom" and GSK's "manipulation of the United States patent system" to go after Moderna.

  • December 12, 2024

    WGA Urges Major Studios To Take Legal Action Over AI 'Theft'

    The Writers Guild of America on Wednesday called on several major entertainment studios to swiftly take legal action against technology companies they assert are stealing writers' works to train artificial intelligence systems and making billions of dollars from the "wholesale theft."

Expert Analysis

  • 8 Childhood Lessons That Can Help You Be A Better Attorney

    Author Photo

    A new school year is underway, marking a fitting time for attorneys to reflect on some fundamental life lessons from early childhood that offer a framework for problems that no legal textbook can solve, say Chris Gismondi and Chris Campbell at DLA Piper.

  • 2nd Circ. Provides NY Pathway For Fighting Foreign Infringers

    Author Photo

    A recent decision from the U.S. Court of Appeals for the Second Circuit provides a road map for expeditiously obtaining personal jurisdiction in New York against foreign trademark infringers based on a single purchase of counterfeit goods, meaning the Second Circuit could now be the preferred venue for combating foreign infringement, says Jeffrey Ratinoff at Spencer Fane.

  • Opinion

    This Election, We Need To Talk About Court Process

    Author Photo

    In recent decades, the U.S. Supreme Court has markedly transformed judicial processes — from summary judgment standards to notice pleadings — which has, in turn, affected individuals’ substantive rights, and we need to consider how the upcoming presidential election may continue this pattern, says Reuben Guttman at Guttman Buschner.

  • Consider Best Legal Practices For Commissioning Public Art

    Author Photo

    Commissioning public art for real estate projects can provide many benefits to real estate developers and the public, but it's important to understand the unique legal and contracting aspects of the process to ensure that projects are completed on time and on budget, says Sarah Conley Odenkirk at ArtConverge.

  • A Look At The PTAB's Assessment Of Prior Art Exceptions

    Author Photo

    The Patent Trial and Appeal Board's approach over the last 10 years to assessing Section 102(b) prior art exceptions reveals a few trends, including that evidence of common ownership may have a higher likelihood of successfully disqualifying prior art under Section 102(b)(2)(C) at the institution stage, say Louis Panzica and David Holman at Sterne Kessler.

  • Series

    Playing Diplomacy Makes Us Better Lawyers

    Author Photo

    Similar to the practice of law, the rules of Diplomacy — a strategic board game set in pre-World War I Europe — are neither concise nor without ambiguity, and weekly gameplay with our colleagues has revealed the game's practical applications to our work as attorneys, say Jason Osborn and Ben Bevilacqua at Winston & Strawn.

  • How Patent Litigation Is Changing Amid Decline In Filings

    Author Photo

    Marked by a notable decline in case filings and preferred venue shifts, patent litigation has undergone significant changes over the last decade and litigation hot spots have shifted, encouraging a more strategic approach to patent disputes, says Saishruti Mutneja at Winston & Strawn.

  • Primer On Chinese Trade Secret Disputes For US Practitioners

    Author Photo

    Increasing cross-border disputes over trade secret misappropriation between U.S. and Chinese entities emphasize the need for U.S. practitioners to navigate China's legal landscape following recent reforms that enhance the viability of litigation in Chinese courts, say attorneys at Jones Day.

  • Mental Health First Aid: A Brief Primer For Attorneys

    Author Photo

    Amid a growing body of research finding that attorneys face higher rates of mental illness than the general population, firms should consider setting up mental health first aid training programs to help lawyers assess mental health challenges in their colleagues and intervene with compassion, say psychologists Shawn Healy and Tracey Meyers.

  • Licensing And Protections For Voice Actors In The Age Of AI

    Author Photo

    While two recently enacted California laws and other recent state and federal legislation largely focus on protecting actors and musicians from the unauthorized use of their digital likenesses by generative artificial intelligence systems, the lesser-known community of professional voice actors also stands to benefit, says attorney Scott Mortman.

  • Opinion

    Failure To Use Apportionment Has Distorted Patent Damages

    Author Photo

    Apportionment is the solution to the problem of inflated patent infringement damages, and courts should return to focusing on the smallest saleable unit as the starting point for apportionment analysis, say William Lee at WilmerHale and Mark Lemley at Stanford Law School.

  • Series

    Collecting Art Makes Me A Better Lawyer

    Author Photo

    The therapeutic aspects of appreciating and collecting art improve my legal practice by enhancing my observation skills, empathy, creativity and cultural awareness, says attorney Michael McCready.

  • Takeaways From Novo Nordisk's Fight For Market Exclusivity

    Author Photo

    Generic competitors’ challenge to Novo Nordisk’s patents in hopes of capturing a portion of the rapidly expanding Type 2 diabetes and obesity treatment market highlights the role of abbreviated new drug application litigation, inter partes review and multidistrict litigation in patent defense, says Pedram Sameni at Patexia.

  • Using Primacy And Recency Effects In Opening Statements

    Author Photo

    By understanding and strategically employing the primacy and recency effects in opening statements, attorneys can significantly enhance their persuasive impact, ensuring that their narrative is both compelling and memorable from the outset, says Bill Kanasky at Courtroom Sciences.

  • Opinion

    Bill Is Key To Protecting US Economy From Patent Piracy

    Author Photo

    It is critical that Congress pass a recently introduced bill that would protect U.S. investors from intellectual property theft by restoring court-ordered injunctions as the default remedy in patent infringement cases to ensure inventors get the justice they deserve, says Andrei Iancu at Sullivan & Cromwell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!